Clinical Trials
229 trialsQuality of Life and Sexuality After Pelvic Exenteration for Gynecologic Cancer
Tampere University Hospital
Nelfinavir, Cisplatin, and External Beam Radiation Therapy for the Treatment of Locally Advanced Vulvar Cancer That Cannot Be Removed by Surgery
M.D. Anderson Cancer Center
Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer
NRG Oncology
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
National Cancer Institute (NCI)
PIERCE
AGO Research GmbH
Reiki-Brachy
University of Utah
GEORGIA
Ohio State University Comprehensive Cancer Center
A Study Evaluating the Effect of Frozen-Section Directed Excision Surgery on Vulvar Dysplasia
Wake Forest University Health Sciences
DOVE
Yonsei University
Cisplatin+Pembrolizumab+RT in Vulvar Cancer
Massachusetts General Hospital
DP-04
AstraZeneca
DaVulvaRec
University of Aarhus
Vaginal DHEA to Improve Vaginal Health After Radiation for Women With Gynecologic, Anal or Rectal Cancer
Ohio State University Comprehensive Cancer Center
ANTARES
Instituto do Cancer do Estado de São Paulo
TraveraRTGx
Travera Inc
IGNITE-V
Hamilton Health Sciences Corporation
A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Small Bowel, and Colon Cancers
National Institutes of Health Clinical Center (CC)
MITO VULVA-01
National Cancer Institute, Naples
LETSGO
Sorlandet Hospital HF
(CLOCS-2)
Imperial College London
ANVU
Queensland Centre for Gynaecological Cancer
GYNCOG
Northwestern University
Paclitaxel Therapeutic Drug Monitoring in Cancer Patients
Wake Forest University Health Sciences
E7 TCR T Cells for Human Papillomavirus-Associated Cancers
National Institutes of Health Clinical Center (CC)
Longitudinal Evaluation of Women Undergoing Pelvic Surgery for the Treatment of Gynecologic Cancer
M.D. Anderson Cancer Center
Electrochemotherapy for Recurrent Vulvar Cancer
Institute of Oncology Ljubljana
Intratreatment FDG-PET During Radiation Therapy for Gynecologic and Gastrointestinal Cancers
Duke University
E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers
Rutgers, The State University of New Jersey
E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers
Rutgers, The State University of New Jersey
Carbon Nanoparticle-Loaded Iron in the Treatment of Advanced Solid Tumor
Sichuan Enray Pharmaceutical Sciences Company
NODE
Queensland Centre for Gynaecological Cancer
A Single-arm, Multicenter Clinical Study of Becotatug Vedotin Combined With Zimberelimab in the Treatment of Recurrent and Metastatic Cervical Cancer, Vulvar Cancer and Vaginal Cancer
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types
University of Florida
Immunotherapy-related CRP Kinetics in Metastatic Gynecological Malignancies
University Hospital Tuebingen
3D Printed Custom Applicators for HDR BT (DISCO)
Royal North Shore Hospital
Virtual Mental Health Intervention to Address Fear of Progression for Women With High Risk or Stage III-IV Gynecologic or Breast Cancer
City of Hope Medical Center
SCANDARE
Institut Curie
STRIVE
British Columbia Cancer Agency
DOSTCONICG
Cukurova University
AKIR001
Karolinska University Hospital
e-Health Intervention (Day-by-Day) for the Management of Fear of Progression in Women With Stage III or IV Gynecologic Cancer: A Pilot Study
City of Hope Medical Center
Potlako+
Brigham and Women's Hospital
Image-Guided Gynecologic Brachytherapy
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Contribution of Oncovascular Surgery in the Treatment of Gynecological Advanced Malignant Diseases.
National Cancer Institute, Naples
Survey on Lymphedema After Sentinel Lymph Node Biopsy in People With Cervical or Vulvar Cancer
Memorial Sloan Kettering Cancer Center
Study of Near-Infrared Imaging With Indocyanine Green for Detection of Sentinel Lymph Nodes in People With Vulvar Cancer
Memorial Sloan Kettering Cancer Center
Belzutifan in Recurrent Clear Cell Carcinoma of Gynecologic Origin
Dana-Farber Cancer Institute
SLN Mapping and ICG Dye for Vulvar Cancer
Tufts Medical Center
KEYNOTE 158
Merck Sharp & Dohme LLC
Simulation Supported Vulva Cancer and Self-Examination on Knowledge, Skills and Attitude
Trakya University